SCIOS INC. andIndenture • August 6th, 2002 • Scios Inc • Pharmaceutical preparations • New York
Permitted Use: Research and development, sales, marketing, administration, and offices Broker: Cornish and Carey Commercial -- representing Sublanlord CRESA Partners, LLC -- representing tenant Exhibits/Attachments: Exhibit A -- Floor Plan Premises...Lease Agreement • June 20th, 2001 • Scios Inc • Pharmaceutical preparations • California
EXHIBIT 10.1 REGISTRATION RIGHTS AGREEMENT Dated as of August 5, 2002Registration Rights Agreement • August 6th, 2002 • Scios Inc • Pharmaceutical preparations • New York
ARTICLE I DEFINITIONSScios Inc • January 24th, 2000 • Pharmaceutical preparations
WITNESSETHPledge Agreement • August 6th, 2002 • Scios Inc • Pharmaceutical preparations • New York
SCIOS INC.Underwriting Agreement • June 22nd, 2001 • Scios Inc • Pharmaceutical preparations • California
EXHIBIT 10.40 SLB/CS(R062599) BIOTECH EQUIPMENT SCHEDULE SCHEDULE NO.003 DATED THIS 09-17-99 TO MASTER LEASE AGREEMENT DATED AS OF July 16, 1993Master Lease Agreement • February 7th, 2000 • Scios Inc • Pharmaceutical preparations
EXHIBIT 10.3 CONTROL AGREEMENT THIS CONTROL AGREEMENT (the "Agreement"), dated as of August 5, 2002, by and among SCIOS INC. (the "Pledgor"), WELLS FARGO BANK, NATIONAL ASSOCIATION, in its capacity as trustee (the "Trustee") for the Holders (as...Control Agreement • August 6th, 2002 • Scios Inc • Pharmaceutical preparations • New York
WITNESSETH:Lease Agreement • June 20th, 2001 • Scios Inc • Pharmaceutical preparations
PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONSPurchase and Sale Agreement • October 13th, 1999 • Scios Inc • Pharmaceutical preparations • California
RECITALSLicense and Supply Agreement • May 2nd, 2002 • Scios Inc • Pharmaceutical preparations • New York
EXHIBIT 4.2 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT AS SET FORTH BELOW. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS...Scios Inc • August 6th, 2002 • Pharmaceutical preparations
EXHIBIT 10.54 BNP AGREEMENT (1995) entered into as of November 17, 1995 by and between SCIOS NOVA INC. 2450 Bayshore Parkway Mountain View, CA 94043/USA (hereinafter referred to as "SCIOS NOVA") and BIOCHEMIE GESELLSCHAFT M.B.H. A-6250 Kundl/Austria...Confidential Treatment Requested • August 14th, 2002 • Scios Inc • Pharmaceutical preparations
NESIRITIDE)Warrant Agreement • March 15th, 2002 • Scios Inc • Pharmaceutical preparations • New York
SCIOS INC. September 8, 1998 Mr. Richard B. Brewer 115 Ericson Road Hillsborough, CA 94010 Dear Dick: On behalf of the Board of Directors and the senior management of Scios, Inc. ("Scios" or the "Company"), I am very pleased to extend to you our offer...Scios Inc • March 29th, 1999 • Pharmaceutical preparations • California
Lease between Sobrato Interests III and Scios, Inc.Scios Inc • November 12th, 2002 • Pharmaceutical preparations • California
Lease between Sobrato Interests III and Scios Inc.Scios Inc • November 12th, 2002 • Pharmaceutical preparations • California
RECITALS:Settlement Agreement • February 1st, 2000 • Scios Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER Dated as of February 10, 2003 Among JOHNSON & JOHNSON, SATURN MERGER SUB, INC. And SCIOS INC.Agreement and Plan of Merger • February 11th, 2003 • Scios Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 10, 2003, among JOHNSON & JOHNSON, a New Jersey corporation (“Parent”), SATURN MERGER SUB, INC., a Delaware corporation and a wholly owned Subsidiary of Parent (“Sub”), and SCIOS INC., a Delaware corporation (the “Company”).
ContractWarrant Agreement • March 30th, 2001 • Scios Inc • Pharmaceutical preparations • New York
Exhibit 10.44 ALLIANCE AGREEMENT — NATRECOR® (NESIRITIDE) This Agreement (the “Agreement”) is made as of January 10, 2001 by and between Scios Inc., a Delaware corporation whose headquarters is located at 820 W. Maude Avenue, Sunnyvale, CA 94085 (“Scios”), Innovex L.P., a limited partnership whose address is 10 Waterview Blvd., Parsippany, NJ 07054 (“Innovex”), and PharmaBio Development, Inc., a North Carolina corporation whose address is 4709 Creekstone Drive, Durham, NC 27703 (“PharmaBio”). Background and Overview of the Alliance
PROCESSING AND SUPPLY AGREEMENT - Natrecor(R) BNP between ABBOTT LABORATORIES and SCIOS INC.Processing and Supply Agreement • November 12th, 2002 • Scios Inc • Pharmaceutical preparations • Delaware
PROCESSING AND SUPPLY AGREEMENT—NatrecorR BNP between ABBOTT LABORATORIES and SCIOS INC.Confidential Treatment Requested • January 9th, 2003 • Scios Inc • Pharmaceutical preparations • Delaware
This Agreement is made effective as of December 1, 1997 (the “Effective Date”), by and between SCIOS INC., a Delaware corporation having its principal place of business at 2450 Bayshore Parkway, Mountain View, California 94043 (“Scios”), and ABBOTT LABORATORIES, an Illinois corporation having its principal place of business at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 (“Abbott”).
BNP AGREEMENT (1995)Confidential Treatment Requested • January 9th, 2003 • Scios Inc • Pharmaceutical preparations
WHEREAS, SCIOS NOVA is seeking to start Phase III clinical trials and obtain regulatory approval of its NATRECOR® brand brain natriuretic peptide (“BNP”) for the treatment of acute congestive heart failure and is seeking a long-term source of supply of BNP made by recombinant manufacture; and
WITNESSETH:Confidential Treatment Requested • November 12th, 2002 • Scios Inc • Pharmaceutical preparations • New York
RECITALSNote Agreement and Preferred Stock Purchase Agreement • February 7th, 2000 • Scios Inc • Pharmaceutical preparations • California
SCIOS INC.,First Supplemental Indenture • April 29th, 2003 • Scios Inc • Pharmaceutical preparations • New York
CROSS-LICENSE AGREEMENTConfidential Treatment Requested • January 9th, 2003 • Scios Inc • Pharmaceutical preparations • New York
This Agreement (“Agreement”) made and entered into as of May 13, 1998 (“Effective Date”), by and between SHIONOGI & CO., LTD., a Japanese corporation having a principal place of business at 1-8, Doshomachi 3-chome, Chuo-Ku, Osaka 541-0045, Japan (“Shionogi”), and SCIOS INC., a Delaware corporation with a principal place of business at 820 West Maude Avenue, Sunnyvale, CA 94085, U.S.A. (“Scios”),
AMENDMENT NO.4 TO LEASEScios Inc • June 20th, 2001 • Pharmaceutical preparations
